Consolidated Balance Sheet (USD $) In Millions, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
ASSETS
Cash and cash equivalents	$ 2,407		$ 3,815
Restricted cash and cash equivalents	784		1,721
Investments in marketable securities	7,131		5,389
Finance receivables, net	65,893		65,176
Investments in operating leases, net	31,128		24,769
Other assets	2,282		1,870
Total assets	109,625		102,740
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	90,231		85,367
Deferred income taxes	7,519	[1]	6,747	[1]
Other liabilities	3,355		2,888
Total liabilities	101,105		95,002
Commitments and contingencies (See Note 14)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at March 31, 2015 and 2014	915		915
Additional paid-in capital	2		2
Accumulated other comprehensive income	220		200
Retained earnings	7,383		6,621
Total shareholder's equity	8,520		7,738
Total liabilities and shareholder's equity	109,625		102,740
Variable Interest Entity, Primary Beneficiary
ASSETS
Finance receivables, net	11,509		9,501
Investments in operating leases, net	1,193		156
Other assets	15		7
Total assets	12,717		9,664
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	10,837		8,158
Other liabilities	3		2
Total liabilities	$ 10,840		$ 8,160

[1] Balance includes deferred tax liabilities attributable to unrealized gain or loss included in accumulated other comprehensive income or loss, net of $136 million and $124 million at March 31, 2015 and 2014, respectively. The change in this deferred liability is not included in total deferred tax expense.